RCKT
ROCKET PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.37
−3.71%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.39
- Revenue estimate
- $200.0K
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- $1.08
- EPS estimate
- $0.86
- Revenue actual
- —
- Revenue estimate
- $222.2K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +6.5%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $12
- PT range
- $9.00 – $15
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | $0.86 | $1.08 | Beat 25.58% | — |
| May 7, 2026 | -$0.41 | -$0.42 | Miss -2.44% | — |
| Nov 6, 2025 | -$0.48 | -$0.45 | Beat 6.25% | — |
| Aug 7, 2025 | -$0.57 | -$0.59 | Miss -3.51% | — |
| May 8, 2025 | -$0.59 | -$0.56 | Beat 5.08% | — |
| Feb 27, 2025 | -$0.68 | -$0.62 | Beat 8.82% | — |
| Nov 7, 2024 | -$0.78 | -$0.71 | Beat 8.97% | — |
| Feb 26, 2024 | -$0.80 | -$0.64 | Beat 20.00% | $10.3M |
| Aug 10, 2023 | -$0.80 | -$0.82 | Miss -2.50% | — |
| May 4, 2023 | -$0.86 | -$0.73 | Beat 15.12% | — |
| Feb 27, 2023 | -$0.81 | -$0.92 | Miss -13.58% | — |
| Nov 3, 2022 | -$0.77 | -$0.87 | Miss -12.99% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026